Vera Therapeutics, Inc. (VERA)
41.73
-0.42
(-1.00%)
USD |
NASDAQ |
Feb 20, 15:20
Vera Therapeutics EPS Diluted (Quarterly) : -1.258 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.098 |
| Eli Lilly & Co. | 7.024 |
| MannKind Corp. | 0.0256 |
| Janux Therapeutics, Inc. | -0.392 |
| Moderna, Inc. | -2.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -80.29M |
| Total Expenses (Quarterly) | 80.29M |
| Enterprise Value | 2.274B |
| Earnings Yield | -9.56% |
| Normalized Earnings Yield | -9.558 |